Editorial

Pharmaceutical Manufacturing Plan for Africa is critical for pandemic preparedness, prevention and response

Michael Mynhardt, Nicaise Ndembi
Journal of Public Health in Africa | Vol 14, No 11 | a38 | DOI: https://doi.org/10.4081/jphia.2023.2861 | © 2024 Michael Mynhardt, Nicaise Ndembi | This work is licensed under CC Attribution 4.0
Submitted: 14 March 2024 | Published: 30 November 2023

About the author(s)

Michael Mynhardt, Group Executive at Avacare Health Global, Managing Director at Barrs Pharmaceutical Industries (Pty) Ltd, South Africa
Nicaise Ndembi, Office of The Director General of The Africa Center for Disease Control and Prevention (Africa CDC), Souh Africa

Full Text:

PDF (155KB)

Abstract

No abstract available.


Keywords

No related keywords in the metadata.

Metrics

Total abstract views: 1733
Total article views: 1176

 

Crossref Citations

1. The influence of institutional logics on vaccine development, production and distribution in Africa
Richard Chawana, Anastacia Mamabolo, Evangelos Apostoleris
International Journal of Operations & Production Management  vol: 45  issue: 2  first page: 355  year: 2025  
doi: 10.1108/IJOPM-11-2023-0896

2. Rethinking corruption: a decolonial inquiry into the intersection of historical systems and anti-corruption efforts
Nana Koomson, Tolulope Ojo, Eustace Orleans-Lindsay, Andrea Bowra
Journal of Pharmaceutical Health Services Research  vol: 16  issue: 3  year: 2025  
doi: 10.1093/jphsr/rmaf010

3. The Need for Lenacapavir Compulsory Licences in Ending the HIV Epidemic
Andrew Hill, Mark J Siedner, Cassandra Fairhead, Francois Venter
Clinical Infectious Diseases  vol: 81  issue: 3  first page: 547  year: 2025  
doi: 10.1093/cid/ciaf115